Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users
- 8 December 2010
- journal article
- research article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 55 (1), 76-85
- https://doi.org/10.1016/j.jhep.2010.10.033
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Effective Treatment of Injecting Drug Users With Recently Acquired Hepatitis C Virus InfectionGastroenterology, 2010
- Hepatitis C Treatment for Injection Drug Users: A Review of the Available EvidenceClinical Infectious Diseases, 2009
- Review article: adherence to medication for chronic hepatitis C – building on the model of human immunodeficiency virus antiretroviral adherence researchAlimentary Pharmacology & Therapeutics, 2009
- Adherence to Hepatitis C Virus Therapy and Early Virologic OutcomesClinical Infectious Diseases, 2009
- Diagnosis, management, and treatment of hepatitis C: An updateHepatology, 2008
- Patient education improves adherence to peg-interferon and ribavirin in chronic genotype 2 or 3 hepatitis C virus infection: A prospective, real-life, observational studyWorld Journal of Gastroenterology, 2008
- The New International Health Regulations: An Historic Development for International Law and Public HealthJournal of Law, Medicine & Ethics, 2006
- The short‐form version of the Depression Anxiety Stress Scales (DASS‐21): Construct validity and normative data in a large non‐clinical sampleBritish Journal of Clinical Psychology, 2005
- Barriers to interferon-α therapy are higher in intravenous drug users than in other patients with acute hepatitis CJournal of Hepatology, 2005
- Efficacy of a 24-week course of PEG-interferon α-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearanceJournal of Hepatology, 2004